Search by Drug Name or NDC

    NDC 65162-0596-06 Aspirin and Extended-Release Dipyridamole 25; 200 mg/1; mg/1 Details

    Aspirin and Extended-Release Dipyridamole 25; 200 mg/1; mg/1

    Aspirin and Extended-Release Dipyridamole is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is ASPIRIN; DIPYRIDAMOLE.

    Product Information

    NDC 65162-0596
    Product ID 65162-596_5f2cdfc0-1031-41fe-8929-0a4ef2ea3ec6
    Associated GPIs 85159902206920
    GCN Sequence Number 040303
    GCN Sequence Number Description aspirin/dipyridamole CPMP 12HR 25MG-200MG ORAL
    HIC3 M9P
    HIC3 Description PLATELET AGGREGATION INHIBITORS
    GCN 95347
    HICL Sequence Number 012474
    HICL Sequence Number Description ASPIRIN/DIPYRIDAMOLE
    Brand/Generic Generic
    Proprietary Name Aspirin and Extended-Release Dipyridamole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Aspirin and Extended-Release Dipyridamole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 25; 200
    Active Ingredient Units mg/1; mg/1
    Substance Name ASPIRIN; DIPYRIDAMOLE
    Labeler Name Amneal Pharmaceuticals LLC
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregati
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206392
    Listing Certified Through 2024-12-31

    Package

    NDC 65162-0596-06 (65162059606)

    NDC Package Code 65162-596-06
    Billing NDC 65162059606
    Package 60 CAPSULE in 1 BOTTLE (65162-596-06)
    Marketing Start Date 2016-03-28
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.70842
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description ASPIRIN-DIPYRIDAM ER 25-200 MG
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis